{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:59:53Z","timestamp":1784919593148,"version":"3.55.0"},"reference-count":43,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2010.0787","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:19:15Z","timestamp":1525252755000},"source":"Crossref","is-referenced-by-count":6,"title":["The Treatment of Women With Epilepsy"],"prefix":"10.3238","author":[{"given":"Sabine","family":"Weil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Deppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheyl","family":"Noachtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2010,11,12]]},"reference":[{"key":"10.3238\/arztebl.2010.0787_ref1","unstructured":"Yerby MS: Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy. Neurology 2000; 55: 21\u201331; discussion 54\u201328."},{"key":"10.3238\/arztebl.2010.0787_ref2","doi-asserted-by":"crossref","unstructured":"May TW, Pfafflin M, Coban I, Schmitz B: Frauen und Epilepsie: Bef\u00fcrchtungen, Wissen, Beratungsbedarf. Nervenarzt 2009; 80: 174\u201383.","DOI":"10.1007\/s00115-008-2632-x"},{"key":"10.3238\/arztebl.2010.0787_ref3","doi-asserted-by":"crossref","unstructured":"Herzog AG: Catamenial epilepsy: definition, prevalence, pathophysiology, and treatment. Seizure 2008; 17: 151\u20139.","DOI":"10.1016\/j.seizure.2007.11.014"},{"key":"10.3238\/arztebl.2010.0787_ref4","doi-asserted-by":"crossref","unstructured":"Herzog AG, Klein P, Ransil BJ: Three patterns of catamenial epilepsy. Epilepsia 1997; 38: 1082\u20138.","DOI":"10.1111\/j.1528-1157.1997.tb01197.x"},{"key":"10.3238\/arztebl.2010.0787_ref5","doi-asserted-by":"crossref","unstructured":"Foldvary-Schaefer N, Falcone T: Catamenial epilepsy: pathophysiology, diagnosis, and management. Neurology 2003; 61: 2\u201315.","DOI":"10.1212\/WNL.61.6_suppl_2.S2"},{"key":"10.3238\/arztebl.2010.0787_ref6","doi-asserted-by":"crossref","unstructured":"Bauer J: Interactions between hormones and epilepsy in female patients. Epilepsia 2001; 42(Suppl 3): 20\u20132.","DOI":"10.1046\/j.1528-1157.2001.042suppl.3020.x"},{"key":"10.3238\/arztebl.2010.0787_ref7","doi-asserted-by":"crossref","unstructured":"Bilo L, Meo R: Epilepsy and polycystic ovary syndrome: where is the link? Neurol Sci 2006; 27: 221\u201330.","DOI":"10.1007\/s10072-006-0675-y"},{"key":"10.3238\/arztebl.2010.0787_ref8","doi-asserted-by":"crossref","unstructured":"Herzog AG, Schachter SC: Valproate and the polycystic ovarian syndrome: final thoughts. Epilepsia 2001; 42: 311\u20135.","DOI":"10.1046\/j.1528-1157.2001.33500.x"},{"key":"10.3238\/arztebl.2010.0787_ref9","doi-asserted-by":"crossref","unstructured":"Isojarvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllyla VV: Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993; 329: 1383\u20138.","DOI":"10.1056\/NEJM199311043291904"},{"key":"10.3238\/arztebl.2010.0787_ref10","doi-asserted-by":"crossref","unstructured":"Rauchenzauner M, Haberlandt E, Scholl-Burgi S, et al.: Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children. Epilepsy Res 2008; 80: 142\u20139.","DOI":"10.1016\/j.eplepsyres.2008.03.017"},{"key":"10.3238\/arztebl.2010.0787_ref11","doi-asserted-by":"crossref","unstructured":"Pylvanen V, Pakarinen A, Knip M, Isojarvi J: Insulin-related metabolic changes during treatment with valproate in patients with epilepsy. Epilepsy Behav 2006; 8: 643\u20138.","DOI":"10.1016\/j.yebeh.2006.02.008"},{"key":"10.3238\/arztebl.2010.0787_ref12","doi-asserted-by":"crossref","unstructured":"Schwenkhagen AM, Stodieck SR: Which contraception for women with epilepsy? Seizure 2008; 17: 145\u201350.","DOI":"10.1016\/j.seizure.2007.11.013"},{"key":"10.3238\/arztebl.2010.0787_ref13","doi-asserted-by":"crossref","unstructured":"O'Brien MD, Guillebaud J: Contraception for women with epilepsy. Epilepsia 2006; 47: 1419\u201322.","DOI":"10.1111\/j.1528-1167.2006.00671.x"},{"key":"10.3238\/arztebl.2010.0787_ref14","doi-asserted-by":"crossref","unstructured":"Christensen J, Petrenaite V, Atterman J, et al.: Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial. Epilepsia 2007; 48: 484\u20139.","DOI":"10.1111\/j.1528-1167.2007.00997.x"},{"key":"10.3238\/arztebl.2010.0787_ref15","doi-asserted-by":"crossref","unstructured":"Winawer MR, Shinnar S: Genetic epidemiology of epilepsy or what do we tell families? Epilepsia 2005; 46(Suppl 10): 24\u201330.","DOI":"10.1111\/j.1528-1167.2005.00354.x"},{"key":"10.3238\/arztebl.2010.0787_ref16","doi-asserted-by":"crossref","unstructured":"Eurap Study Group: Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 2006; 66: 354\u201360.","DOI":"10.1212\/01.wnl.0000195888.51845.80"},{"key":"10.3238\/arztebl.2010.0787_ref17","doi-asserted-by":"crossref","unstructured":"Pennell PB: 2005 AES annual course: evidence used to treat women with epilepsy. Epilepsia 2006; 47(Suppl 1): 46\u201353.","DOI":"10.1111\/j.1528-1167.2006.00660.x"},{"key":"10.3238\/arztebl.2010.0787_ref18","doi-asserted-by":"crossref","unstructured":"Morrow J, Russell A, Guthrie E, et al.: Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006; 77: 193\u20138.","DOI":"10.1136\/jnnp.2005.074203"},{"key":"10.3238\/arztebl.2010.0787_ref19","doi-asserted-by":"crossref","unstructured":"Harden CL, Meador KJ, Pennell PB, et al.: Practice parameter update: management issues for women with epilepsy\u2014focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009; 73: 133\u201341.","DOI":"10.1212\/WNL.0b013e3181a6b312"},{"key":"10.3238\/arztebl.2010.0787_ref20","unstructured":"Schmitz B, Denning, D, Dietz, R, Steinhoff B, Mayer, T: Valproate for women with epilepsy; a recommendation of the German Chapter of international League against Epilepsy. Eurap homepage: 2010."},{"key":"10.3238\/arztebl.2010.0787_ref21","doi-asserted-by":"crossref","unstructured":"Marson AG, Al-Kharusi AM, Alwaidh M, et al.: The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1016\u201326.","DOI":"10.1016\/S0140-6736(07)60461-9"},{"key":"10.3238\/arztebl.2010.0787_ref22","doi-asserted-by":"crossref","unstructured":"Meador KJ, Baker GA, Browning N, et al.: Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009; 360: 1597\u2013605.","DOI":"10.1056\/NEJMoa0803531"},{"key":"10.3238\/arztebl.2010.0787_ref23","doi-asserted-by":"crossref","unstructured":"Harden CL, Pennell PB, Koppel BS, et al.: Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009; 73: 142\u20139.","DOI":"10.1212\/WNL.0b013e3181a6b325"},{"key":"10.3238\/arztebl.2010.0787_ref24","doi-asserted-by":"crossref","unstructured":"Bagshaw J, Crawford P, Chappell B: Problems that mothers' with epilepsy experience when caring for their children. Seizure 2008; 17: 42\u20138.","DOI":"10.1016\/j.seizure.2007.06.004"},{"key":"10.3238\/arztebl.2010.0787_ref25","doi-asserted-by":"crossref","unstructured":"Bartl R: Antiepileptika-induzierte Osteopathie. Formen, Pathogenese, Prophylaxe, Fr\u00fcherkennung, Therapie. Dtsch Med Wochenschr 2007; 132: 1475\u20139.","DOI":"10.1055\/s-2007-982057"},{"key":"10.3238\/arztebl.2010.0787_ref26","doi-asserted-by":"crossref","unstructured":"Scharfman HE, MacLusky NJ: The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female. Epilepsia 2006; 47(9): 1423\u201340.","DOI":"10.1111\/j.1528-1167.2006.00672.x"},{"key":"10.3238\/arztebl.2010.0787_ref27","doi-asserted-by":"crossref","unstructured":"Feely M, Gibson J: Intermittent clobazam for catamenial epilepsy: tolerance avoided. J Neurol Neurosurg Psychiatry 1984; 47(12): 1279\u201382.","DOI":"10.1136\/jnnp.47.12.1279"},{"key":"10.3238\/arztebl.2010.0787_ref28","doi-asserted-by":"crossref","unstructured":"Vainionpaa LK, et al.: Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Ann Neurol 1999; 45(4): 444\u201350.","DOI":"10.1002\/1531-8249(199904)45:4<444::AID-ANA5>3.0.CO;2-6"},{"key":"10.3238\/arztebl.2010.0787_ref29","doi-asserted-by":"crossref","unstructured":"Herzog AG, et al.: Reproductive endocrine disorders in men with partial seizures of temporal lobe origin. Arch Neurol 1986; 43(4): 347\u201350.","DOI":"10.1001\/archneur.1986.00520040035015"},{"key":"10.3238\/arztebl.2010.0787_ref30","doi-asserted-by":"crossref","unstructured":"Herzog AG, et al.: Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch Neurol 1986; 43(4): 341\u20136.","DOI":"10.1001\/archneur.1986.00520040029014"},{"key":"10.3238\/arztebl.2010.0787_ref31","doi-asserted-by":"crossref","unstructured":"Herzog AG: Is there a lateralized asymmetry in the sensitivity of the brain to hormones in epilepsy? Epilepsy Behav 2007; 11(2): 157\u20139.","DOI":"10.1016\/j.yebeh.2007.05.008"},{"key":"10.3238\/arztebl.2010.0787_ref32","doi-asserted-by":"crossref","unstructured":"Isojarvi J: Disorders of reproduction in patients with epilepsy: antiepileptic drug related mechanisms. Seizure 2008; 17(2): 111\u20139.","DOI":"10.1016\/j.seizure.2007.11.007"},{"key":"10.3238\/arztebl.2010.0787_ref33","doi-asserted-by":"crossref","unstructured":"Cummings LN, Giudice L, Morrell MJ: Ovulatory function in epilepsy. Epilepsia 1995; 36(4): 355\u20139.","DOI":"10.1111\/j.1528-1157.1995.tb01009.x"},{"key":"10.3238\/arztebl.2010.0787_ref34","unstructured":"Deutsche Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe e.V. ."},{"key":"10.3238\/arztebl.2010.0787_ref35","doi-asserted-by":"crossref","unstructured":"Teramo K, et al.: Fetal heart rate during a maternal grand mal epileptic seizure. J Perinat Med 1979: 7(1): 3\u20136.","DOI":"10.1515\/jpme.1979.7.1.3"},{"key":"10.3238\/arztebl.2010.0787_ref36","doi-asserted-by":"crossref","unstructured":"Pennell, PB: Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 2003; 61(6)(Suppl 2): 35\u201342.","DOI":"10.1212\/WNL.61.6_suppl_2.S35"},{"key":"10.3238\/arztebl.2010.0787_ref37","doi-asserted-by":"crossref","unstructured":"Crawford P: Best practice guidelines for the management of women with epilepsy. Epilepsia 2005; 46(Suppl 9): 117\u201324.","DOI":"10.1111\/j.1528-1167.2005.00323.x"},{"key":"10.3238\/arztebl.2010.0787_ref38","unstructured":"Kommission f\u00fcr Leitlinien der Deutschen Gesellschaft f\u00fcr Neurologie. Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. 4. \u00fcberarbeitete Auflage 2008. Thieme Verlag 2008. (Online: www.dgn.org\/-leitlinien-online.html)."},{"key":"10.3238\/arztebl.2010.0787_ref39","doi-asserted-by":"crossref","unstructured":"Yerby, MS: Management issues for women with epilepsy: neural tube defects and folic acid supplementation. Neurology 2003; 61(6)(Suppl 2): 23\u20136.","DOI":"10.1212\/WNL.61.6_suppl_2.S23"},{"key":"10.3238\/arztebl.2010.0787_ref40","unstructured":"Reiman DM, et al.: A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998; 339(12): 792\u20138."},{"key":"10.3238\/arztebl.2010.0787_ref41","doi-asserted-by":"crossref","unstructured":"Malow BA, et al.: Sleep deprivation does not affect seizure frequency during inpatient video-EEG monitoring. Neurology 2002; 59(9): 1371\u20134.","DOI":"10.1212\/01.WNL.0000031810.15811.9E"},{"key":"10.3238\/arztebl.2010.0787_ref42","doi-asserted-by":"crossref","unstructured":"Tomson T, et al.: Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation. Epilepsia 2007; 48(6): 1111\u20136.","DOI":"10.1111\/j.1528-1167.2007.01032.x"},{"key":"10.3238\/arztebl.2010.0787_ref43","doi-asserted-by":"crossref","unstructured":"Leidenberger F e. Klinische Endokrinologie f\u00fcr Frauen\u00e4rzte. Heidelberg: Springer Verlag 2005","DOI":"10.1007\/b137539"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2010.0787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T14:58:31Z","timestamp":1638802711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2010.0787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,12]]},"references-count":43,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2010.0787","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,12]]}}}